BioInnovation Institute provides EUR 7.8M in financial support as six promising companies enter its Venture House program
Articolo Precedente
Articolo Successivo
To support product innovation and ecosystem growth, the program consists of four executive sprints, each focused on a key development area to help mature the project and ultimately attract further funding. The first sprint focuses on helping companies develop an operational plan, while the following sprints provide training and support in fundraising, partnership, and leadership.
Bobby Soni, Chief Business Officer at BioInnovation Institute, said: "All six of these companies align with BII's mission, to develop solutions to benefit human and planetary health. That is why we are proud to further support these companies through the Venture House program and bring these companies closer to receiving external investment and commercializing their technologies."
All six companies have partaken in BII's Venture Lab program that supports business acceleration, scientific development and team development in which each company received a risk-free convertible loan of EUR 500,000 plus access to labs and offices at the BII's entrepreneurial ecosystem in the center of Copenhagen. Thus, after entering the Venture House program they have received in total EUR 1.8M. The new companies BII has accepted into the Venture House program are:
Since its inception in 2018, BII has supported 100 start-ups and projects with EUR 97 million alongside the venture capital, industry and business expertise it provides to help them accelerate to the next level. In total, BII's start-ups have raised over EUR 428 million in external funding from both local and international investors. Recent company successes include Embark Laboratories, Adcendo, Stipe Therapeutics, Twelve Bio, Octarine Bio, and Cirqle Biomedical.
Read more about the Venture House program here.
About the BioInnovation Institute Foundation:
At BioInnovation Institute (BII), we accelerate world-class life science start-up innovation for the benefit of people and society. As a non-profit institute, BII operates the company creation programs, Bio Studio, Venture Lab and Venture House, to support life science start-ups with knowledge, network, infrastructure and funding of up to 3M EUR per projects and 1,8 M EUR per start-up. With our expertise, network, funding, and infrastructure, we empower startups to succeed and believe in the transformative power of life science innovation. Read more on www.bioinnovationinstitute.com
View original content:https://www.prnewswire.co.uk/news-releases/bioinnovation-institute-provides-eur-7-8m-in-financial-support-as-six-promising-companies-enter-its-venture-house-program-302081967.html
![](https://rt.prnewswire.com/rt.gif?NewsItemId=EN54523&Transmission_Id=202403070305PR_NEWS_EURO_ND__EN54523&DateId=20240307)